Loading...
OTCM
MHTX
Market cap55kUSD
Nov 20, Last price  
0.00USD
Name

Manhattan Scientifics Inc

Chart & Performance

D1W1MN
OTCM:MHTX chart
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
0.94%
Rev. gr., 5y
-18.84%
Revenues
0k
-100.00%
150,000000856,000633,0001,686,000687,000693,000652,000642,00064,000150,000142,000097,00050,00050,00050,0000
Net income
-1m
L-75.53%
-1,517,000-219,000-1,694,000-3,014,000-2,142,000-446,000-43,000-2,287,000-2,090,000-1,928,000-3,805,0008,012,000-6,108,0001,546,000-8,334,000-1,227,0004,314,000-3,665,000-4,760,000-1,165,000
CFO
-190k
L-45.56%
-445,000-751,000-331,000-537,000-700,000-406,000462,000-1,196,000-1,078,000-964,000-2,535,0003,415,000-4,558,000-791,000-682,000-316,000-388,000-421,000-349,000-190,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Manhattan Scientifics, Inc., a technology incubator, engages in the development and commercialization of life-enhancing technologies in the United States. It develops technologies in the areas of nano-technologies and nano-medicine. The company was formerly known as Grand Enterprises, Inc. Manhattan Scientifics, Inc. was founded in 1992 and is based in New York, New York.
IPO date
May 24, 2000
Employees
1
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT